Showing results (551-560 of 572) with videos related to

Sort By:
Pageof 58
The Lancet. Infectious Diseases|March 11, 2020
Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort studyDavid van Duin, Cesar A Arias, Lauren Komarow, et al.
Nature Communications|January 4, 2018
Protein-inspired antibiotics active against vancomycin- and daptomycin-resistant bacteriaMark A T Blaskovich, Karl A Hansford, Yujing Gong, et al.
Antimicrobial Agents and Chemotherapy|August 7, 2019
Antecedent Carbapenem Exposure as a Risk Factor for Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae and Carbapenemase-Producing EnterobacteriaceaeKalisvar Marimuthu, Oon Tek Ng, Benjamin Pei Zhi Cherng, et al.
Science Translational Medicine|November 19, 2020
Repurposing a neurodegenerative disease drug to treat Gram-negative antibiotic-resistant bacterial sepsisDavid M P De Oliveira, Lisa Bohlmann, Trent Conroy, et al.
The Journal of Antimicrobial Chemotherapy|January 8, 2017
Development and validation of the INCREMENT-ESBL predictive score for mortality in patients with bloodstream infections due to extended-spectrum-β-lactamase-producing EnterobacteriaceaeZaira Raquel Palacios-Baena, Belén Gutiérrez-Gutiérrez, Marina De Cueto, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 22, 2023
Clinical Outcomes and Bacterial Characteristics of Carbapenem-resistant Acinetobacter baumannii Among Patients From Different Global RegionsMinggui Wang, Lizhao Ge, Liang Chen, et al.
The Lancet. Infectious Diseases|November 12, 2021
Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort studyMinggui Wang, Michelle Earley, Liang Chen, et al.
The Journal of Antimicrobial Chemotherapy|May 16, 2021
Combination versus monotherapy as definitive treatment for Pseudomonas aeruginosa bacteraemia: a multicentre retrospective observational cohort studyTanya Babich, Pontus Naucler, John Karlsson Valik, et al.
International Journal of Antimicrobial Agents|November 27, 2019
Risk factors for mortality among patients with Pseudomonas aeruginosa bacteraemia: a retrospective multicentre studyTanya Babich, Pontus Naucler, John Karlsson Valik, et al.
Infectious Diseases and Therapy|May 25, 2022
Duration of Treatment for Pseudomonas aeruginosa Bacteremia: a Retrospective StudyTanya Babich, Pontus Naucler, John Karlsson Valik, et al.
Pageof 58